All In MedTech

Device Trial Radar · NCT02793492

Misago® RX Self-expanding Peripheral Stent for Common and/or External Iliac Artery

OSPREY ILIAC: Occlusive/Stenotic Peripheral Artery REvascularization StudY for Common and/or External ILIAC Artery Using the Misago® RX Self-expanding Peripheral Stent

Last checked: Nov 20, 2026Latest source record: Jul 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

75

Actual

Start

Aug 30, 2022

Primary completion

Feb 24, 2025

Study completion Jul 1, 2026

Sponsor

Lead sponsor
Terumo Medical CorporationPublic (4543.T)
Sponsor type
Industry
First posted
Jun 8, 2016

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multi-center, single arm, non-randomized, prospective clinical study using the Misago® RX Self-expanding Peripheral Stent for treatment of de novo, restenotic, and/or occlusive lesion(s) of the common and/or external iliac artery.

Conditions

  • Iliac Artery Stenosis

Interventions

  • Misago® RX Self-expanding Peripheral StentDevice

    the Misago® RX Self-expanding Stent is a bare metal, nitinol stent

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Freedom from the composite Major Adverse Event rate, defined as periprocedural related death, amputation of the target limb, and clinically driven TLR assessed at 9 months post-procedure.Time frame: 9 months post-procedure

Locations

9 sites in 1 country. Site status is shown where the registry gives one.

  • ClinRe Inc. Advanced Heart and Vein Center

    Thornton, Colorado

8 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.